
LINK . SPRINGER . COM {
}
Title:
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes | Breast Cancer Research and Treatment
Description:
The prognostic significance of tumor-associated FOXP3+ regulatory T cells (Tregs) and CD8+ cytotoxic T lymphocytes (CTLs) in invasive breast carcinomas is studied. Tregs and CTLs were assessed by immunohistochemistry in 1270 cases of invasive breast carcinoma for their associations with patient survival, histopathologic features, and molecular subtypes. Infiltrates of Tregs and CTLs were observed within tumor bed and in the tissue surrounding tumor. Within tumor bed, increased infiltration of Tregs and CTLs was significantly more common in those with unfavorable histologic features, including high histologic grade and negative ER and PR status. In addition, high density Treg infiltration was also associated with tumor HER2 overexpression, decreased overall survival (OS) and progression-free survival (PFS). In tissue surrounding tumor, in contrast, high CTL/Treg ratio was found to be significantly associated with improved OS and PFS. These prognostic associations were confirmed by multivariate analysis. Furthermore, the density of Treg infiltrates within tumors was inversely correlated with the prognosis of the molecular subtypes of tumors. The ratio of CTL/Treg infiltrates in the surrounding tissue was also significantly higher in luminal than non-luminal subtypes of carcinoma. The prognostic significances of Tregs and CTLs in breast carcinoma depend on their relative density and location. The density of intratumoral Treg infiltrates and the peritumoral CTL/Treg ratio are independent prognostic factors and correlated with the prognosis of the molecular subtypes of breast carcinoma, which may serve as potential target for stratifying immunotherapy to battle against the aggressive subtypes of breast carcinoma.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don't see any clear sign of profit-making.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
article, cancer, pubmed, google, scholar, breast, cas, cells, regulatory, carcinoma, tumor, cell, survival, subtypes, lymphocytes, clin, prognostic, research, cytotoxic, molecular, res, access, tumorinfiltrating, foxp, infiltration, tregs, infiltrates, privacy, cookies, content, ctls, invasive, density, prognosis, intratumoral, outcome, med, oncol, publish, search, lang, zhang, fan, surrounding, high, ratio, tumors, immunotherapy, open, human,
Topics {✒️}
tumor-infiltrating t-cells—friend month download article/chapter small-cell lung cancer vanderbilt–ingram cancer center peritumoral ctl/treg ratio high ctl/treg ratio full article pdf related subjects innovative research team privacy choices/manage cookies tumor-infiltrating cytotoxic infiltrating ductal carcinoma tumor-infiltrating lymphocytes tumor infiltrating lymphocytes adverse clinical outcome temple university hospital invasive breast carcinoma invasive breast carcinomas cells predict outcome ctl/treg infiltrates tissue surrounding tumor invasive micropapillary carcinoma cheang mc metastatic breast cancer breast cancer prevention breast carcinoma depend inhibits tumor growth intratumoral lymphoid structures pancreatic ductal adenocarcinorna epithelial ovarian cancer breast cancer subtypes breast cancer survival tumor-infiltrating foxp3+ li fu tumor her2 overexpression tumor specific cytolysis vanderbilt epidemiology center tumor-infiltrating cd4 t-regulatory cells cell infiltrates varies european economic area unfavorable histologic features progression-free survival conejo-garcia jr long-term follow article liu breast cancer pathology independent prognostic factors pathological prognostic factors conditions privacy policy
Questions {❓}
- Parmiani G (2005) Tumor-infiltrating T-cells—friend or foe of neoplastic cells?
- Yu P, Fu YX (2006) Tumor-infiltrating T lymphocytes: friends or foes?
Schema {🗺️}
WebPage:
mainEntity:
headline:CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
description:The prognostic significance of tumor-associated FOXP3+ regulatory T cells (Tregs) and CD8+ cytotoxic T lymphocytes (CTLs) in invasive breast carcinomas is studied. Tregs and CTLs were assessed by immunohistochemistry in 1270 cases of invasive breast carcinoma for their associations with patient survival, histopathologic features, and molecular subtypes. Infiltrates of Tregs and CTLs were observed within tumor bed and in the tissue surrounding tumor. Within tumor bed, increased infiltration of Tregs and CTLs was significantly more common in those with unfavorable histologic features, including high histologic grade and negative ER and PR status. In addition, high density Treg infiltration was also associated with tumor HER2 overexpression, decreased overall survival (OS) and progression-free survival (PFS). In tissue surrounding tumor, in contrast, high CTL/Treg ratio was found to be significantly associated with improved OS and PFS. These prognostic associations were confirmed by multivariate analysis. Furthermore, the density of Treg infiltrates within tumors was inversely correlated with the prognosis of the molecular subtypes of tumors. The ratio of CTL/Treg infiltrates in the surrounding tissue was also significantly higher in luminal than non-luminal subtypes of carcinoma. The prognostic significances of Tregs and CTLs in breast carcinoma depend on their relative density and location. The density of intratumoral Treg infiltrates and the peritumoral CTL/Treg ratio are independent prognostic factors and correlated with the prognosis of the molecular subtypes of breast carcinoma, which may serve as potential target for stratifying immunotherapy to battle against the aggressive subtypes of breast carcinoma.
datePublished:2011-06-30T00:00:00Z
dateModified:2011-06-30T00:00:00Z
pageStart:645
pageEnd:655
sameAs:https://doi.org/10.1007/s10549-011-1647-3
keywords:
Breast carcinoma
Cytotoxic T cell
Regulatory T cell
Survival
Molecular subtype
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig4_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Fangfang Liu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Ronggang Lang
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Jing Zhao
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xinmin Zhang
affiliation:
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Gordon A. Pringle
affiliation:
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Yu Fan
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Dong Yin
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Feng Gu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Zhi Yao
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Li Fu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
description:The prognostic significance of tumor-associated FOXP3+ regulatory T cells (Tregs) and CD8+ cytotoxic T lymphocytes (CTLs) in invasive breast carcinomas is studied. Tregs and CTLs were assessed by immunohistochemistry in 1270 cases of invasive breast carcinoma for their associations with patient survival, histopathologic features, and molecular subtypes. Infiltrates of Tregs and CTLs were observed within tumor bed and in the tissue surrounding tumor. Within tumor bed, increased infiltration of Tregs and CTLs was significantly more common in those with unfavorable histologic features, including high histologic grade and negative ER and PR status. In addition, high density Treg infiltration was also associated with tumor HER2 overexpression, decreased overall survival (OS) and progression-free survival (PFS). In tissue surrounding tumor, in contrast, high CTL/Treg ratio was found to be significantly associated with improved OS and PFS. These prognostic associations were confirmed by multivariate analysis. Furthermore, the density of Treg infiltrates within tumors was inversely correlated with the prognosis of the molecular subtypes of tumors. The ratio of CTL/Treg infiltrates in the surrounding tissue was also significantly higher in luminal than non-luminal subtypes of carcinoma. The prognostic significances of Tregs and CTLs in breast carcinoma depend on their relative density and location. The density of intratumoral Treg infiltrates and the peritumoral CTL/Treg ratio are independent prognostic factors and correlated with the prognosis of the molecular subtypes of breast carcinoma, which may serve as potential target for stratifying immunotherapy to battle against the aggressive subtypes of breast carcinoma.
datePublished:2011-06-30T00:00:00Z
dateModified:2011-06-30T00:00:00Z
pageStart:645
pageEnd:655
sameAs:https://doi.org/10.1007/s10549-011-1647-3
keywords:
Breast carcinoma
Cytotoxic T cell
Regulatory T cell
Survival
Molecular subtype
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig4_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Fangfang Liu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Ronggang Lang
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Jing Zhao
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xinmin Zhang
affiliation:
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Gordon A. Pringle
affiliation:
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Yu Fan
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Dong Yin
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Feng Gu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Zhi Yao
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Li Fu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Fangfang Liu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
name:Ronggang Lang
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
name:Jing Zhao
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
name:Xinmin Zhang
affiliation:
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
type:Organization
name:Gordon A. Pringle
affiliation:
name:Temple University Hospital
address:
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
type:PostalAddress
type:Organization
name:Yu Fan
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
name:Dong Yin
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
name:Feng Gu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
name:Zhi Yao
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
name:Li Fu
affiliation:
name:Tianjin Medical University Cancer Institute & Hospital
address:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(138)
- https://www.springernature.com/gp/authors income
- How profitable is https://link.springernature.com/home/?
- Learn how profitable https://order.springer.com/public/cart is on a monthly basis
- How much income is https://submission.springernature.com/new-submission/10549/3 earning monthly?
- Get to know what's the income of https://www.springernature.com/gp/librarians/licensing/agc/journals
- How much does https://doi.org/10.1126%2Fscience.1129139 pull in monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17008531's revenue stream
- How much income is http://scholar.google.com/scholar_lookup?&title=Type%2C%20density%2C%20and%20location%20of%20immune%20cells%20within%20human%20colorectal%20tumors%20predict%20clinical%20outcome&journal=Science&doi=10.1126%2Fscience.1129139&volume=313&pages=1960-1964&publication_year=2006&author=Galon%2CJ&author=Costes%2CA&author=Sanchez-Cabo%2CF earning monthly?
- What is the earnings of https://doi.org/10.1056%2FNEJMp058236?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16371629 each month?
- How much income is http://scholar.google.com/scholar_lookup?&title=Tumor-infiltrating%20T-cells%E2%80%94friend%20or%20foe%20of%20neoplastic%20cells%3F&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMp058236&volume=353&pages=2640-2641&publication_year=2005&author=Parmiani%2CG earning monthly?
- What's the profit of https://doi.org/10.1016%2Fj.jri.2005.06.002?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16111767
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Current%20concepts%20of%20tumor-infiltrating%20lymphocytes%20in%20human%20malignancies&journal=J%20Reprod%20Immunol&doi=10.1016%2Fj.jri.2005.06.002&volume=67&pages=35-50&publication_year=2005&author=Chiou%2CSH&author=Sheu%2CBC&author=Chang%2CWC&author=Huang%2CSC&author=Ho%2CHN
- What's the financial outcome of https://doi.org/10.1038%2Flabinvest.3700389?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16446705 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor-infiltrating%20T%20lymphocytes%3A%20friends%20or%20foes%3F&journal=Lab%20Invest&doi=10.1038%2Flabinvest.3700389&volume=86&pages=231-245&publication_year=2006&author=Yu%2CP&author=Fu%2CYX pull in monthly?
- What's https://doi.org/10.1002%2Fhep.20644's gross income?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15791620's gross income?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Compromised%20lymphocytes%20infiltrate%20hepatocellular%20carcinoma%3A%20the%20role%20of%20T-regulatory%20cells&journal=Hepatology&doi=10.1002%2Fhep.20644&volume=41&pages=722-730&publication_year=2005&author=Unitt%2CE&author=Rushbrook%2CSM&author=Marshall%2CA?
- What's the monthly money flow for https://doi.org/10.1038%2Fmodpathol.2008.72?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18469794 generate?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Tumor%20infiltrating%20lymphocytes%20differ%20in%20invasive%20micropapillary%20carcinoma%20and%20medullary%20carcinoma%20of%20breast&journal=Mod%20Pathol&doi=10.1038%2Fmodpathol.2008.72&volume=21&pages=1101-1107&publication_year=2008&author=Guo%2CXJ&author=Fan%2CY&author=Lang%2CRG
- What's the financial intake of https://doi.org/10.1056%2FNEJMoa051424?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16371631 have?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Effector%20memory%20T%20cells%2C%20early%20metastasis%2C%20and%20survival%20in%20colorectal%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa051424&volume=353&pages=2654-2666&publication_year=2005&author=Pages%2CF&author=Berger%2CA&author=Camus%2CM earns monthly
- What is the earnings of https://doi.org/10.1056%2FNEJMoa020177?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12529460?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Intratumoral%20T%20cells%2C%20recurrence%2C%20and%20survival%20in%20epithelial%20ovarian%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa020177&volume=348&pages=203-213&publication_year=2003&author=Zhang%2CL&author=Conejo-Garcia%2CJR&author=Katsaros%2CD
- Find out how much https://doi.org/10.1016%2Fj.imlet.2005.09.006 earns monthly
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16246429?
- How much does http://scholar.google.com/scholar_lookup?&title=Phenotyping%20of%20lymphocytes%20expressing%20regulatory%20and%20effector%20markers%20in%20infiltrating%20ductal%20carcinoma%20of%20the%20breast&journal=Immunol%20Lett&doi=10.1016%2Fj.imlet.2005.09.006&volume=102&pages=229-236&publication_year=2006&author=Leong%2CPP&author=Mohammad%2CR&author=Ibrahim%2CN rake in every month?
- Get to know https://doi.org/10.1002%2F1097-0142%2819940815%2974%3A4%3C1275%3A%3AAID-CNCR2820740416%3E3.0.CO%3B2-Q's earnings
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7914469 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20specific%20cytolysis%20by%20tumor%20infiltrating%20lymphocytes%20in%20breast%20cancer&journal=Cancer&doi=10.1002%2F1097-0142%2819940815%2974%3A4%3C1275%3A%3AAID-CNCR2820740416%3E3.0.CO%3B2-Q&volume=74&pages=1275-1282&publication_year=1994&author=Baxevanis%2CCN&author=Dedoussis%2CGV&author=Papadopoulos%2CNG&author=Missitzis%2CI&author=Stathopoulos%2CGP&author=Papamichail%2CM bring in each month?
- What's the financial intake of https://doi.org/10.1172%2FJCI31202?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17476346's total income per month
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Tregs%20and%20rethinking%20cancer%20immunotherapy&journal=J%20Clin%20Invest&doi=10.1172%2FJCI31202&volume=117&pages=1167-1174&publication_year=2007&author=Curiel%2CTJ?
- Learn how profitable https://doi.org/10.1038%2Fnri1806 is on a monthly basis
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16557261
- How much does http://scholar.google.com/scholar_lookup?&title=Regulatory%20T%20cells%2C%20tumour%20immunity%20and%20immunotherapy&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fnri1806&volume=6&pages=295-307&publication_year=2006&author=Zou%2CW make?
- What's the profit of https://doi.org/10.1038%2Fnm1093?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15322536 pull in?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Specific%20recruitment%20of%20regulatory%20T%20cells%20in%20ovarian%20carcinoma%20fosters%20immune%20privilege%20and%20predicts%20reduced%20survival&journal=Nat%20Med&doi=10.1038%2Fnm1093&volume=10&pages=942-949&publication_year=2004&author=Curiel%2CTJ&author=Coukos%2CG&author=Zou%2CLH?
- Check the income stats for https://doi.org/10.1084%2Fjem.20020110
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12163566?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Phenotype%2C%20localization%2C%20and%20mechanism%20of%20suppression%20of%20CD4%28%2B%29CD25%28%2B%29%20human%20thymocytes&journal=J%20Exp%20Med&doi=10.1084%2Fjem.20020110&volume=196&pages=379-387&publication_year=2002&author=Annunziato%2CF&author=Cosmi%2CL&author=Liotta%2CF?
- How much revenue does https://doi.org/10.4161%2Fcbt.8.1.7131 bring in?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19029829
- How much does http://scholar.google.com/scholar_lookup?&title=Depletion%20of%20CD4%28%2B%29CD25%28high%29%20regulatory%20T%20cells%20from%20tumor%20infiltrating%20lymphocytes%20predominantly%20induces%20Th1%20type%20immune%20response%20in%20vivo%20which%20inhibits%20tumor%20growth%20in%20adoptive%20immunotherapy&journal=Cancer%20Biol%20Ther&doi=10.4161%2Fcbt.8.1.7131&volume=8&pages=66-72&publication_year=2009&author=Xu%2CL&author=Xu%2CW&author=Jiang%2CZ&author=Zhang%2CF&author=Chu%2CY&author=Xiong%2CS make?
- Explore the financials of https://doi.org/10.1073%2Fpnas.0509182102
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16344461 earn?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Intraepithelial%20CD8%28%2B%29%20tumor-infiltrating%20lymphocytes%20and%20a%20high%20CD8%28%2B%29%2Fregulatory%20T%20cell%20ratio%20are%20associated%20with%20favorable%20prognosis%20in%20ovarian%20cancer&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0509182102&volume=102&pages=18538-18543&publication_year=2005&author=Sato%2CE&author=Olson%2CSH&author=Ahn%2CJ have monthly?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-06-2363 generate monthly?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17289884 earning monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=FOXP3%28%2B%29%20regulatory%20T%20cells%20affect%20the%20development%20and%20progression%20of%20hepatocarcinogenesis&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-2363&volume=13&pages=902-911&publication_year=2007&author=Kobayashi%2CN&author=Hiraoka%2CN&author=Yamagami%2CW?
- See how much https://doi.org/10.1200%2FJCO.2006.09.4565 makes per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17577038 earn?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Intratumoral%20balance%20of%20regulatory%20and%20cytotoxic%20T%20cells%20is%20associated%20with%20prognosis%20of%20hepatocellular%20carcinoma%20after%20resection&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.09.4565&volume=25&pages=2586-2593&publication_year=2007&author=Gao%2CQ&author=Qiu%2CSJ&author=Fan%2CJ?
- https://doi.org/10.1158%2F1078-0432.CCR-06-0369's total income per month
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17000676?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Prevalence%20of%20FOXP3%28%2B%29%20regulatory%20T%20cells%20increases%20during%20the%20progression%20of%20pancreatic%20ductal%20adenocarcinorna%20and%20its%20premalignant%20lesions&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0369&volume=12&pages=5423-5434&publication_year=2006&author=Hiraoka%2CN&author=Onozato%2CK&author=Kosuge%2CT&author=Hirohashi%2CS generate?
- What are the total earnings of https://doi.org/10.1158%2F1078-0432.CCR-04-1869?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15746048's earnings
- Income figures for http://scholar.google.com/scholar_lookup?&title=Outcome%20in%20Hodgkin%E2%80%99s%20lymphoma%20can%20be%20predicted%20from%20the%20presence%20of%20accompanying%20cytotoxic%20and%20regulatory%20T%20cells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-1869&volume=11&pages=1467-1473&publication_year=2005&author=Alvaro%2CT&author=Lejeune%2CM&author=Salvado%2CMT
- Monthly income for https://doi.org/10.1200%2FJCO.2007.15.0284
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18802153 make?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Long-term%20survival%20for%20patients%20with%20non-small-cell%20lung%20cancer%20with%20intratumoral%20lymphoid%20structures&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.15.0284&volume=26&pages=4410-4417&publication_year=2008&author=Dieu-Nosjean%2CMC&author=Antoine%2CM&author=Danel%2CC?
- See how much https://doi.org/10.1200%2FJCO.2008.18.7229 makes per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19064967 pull in monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Tumor-infiltrating%20FOXP3%2B%20T%20regulatory%20cells%20show%20strong%20prognostic%20significance%20in%20colorectal%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.18.7229&volume=27&pages=186-192&publication_year=2009&author=Salama%2CP&author=Phillips%2CM&author=Grieu%2CF?
- What's the monthly money flow for https://doi.org/10.1200%2FJCO.2006.05.9584?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17135638 have monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Quantification%20of%20regulatory%20T%20cells%20enables%20the%20identification%20of%20high-risk%20breast%20cancer%20patients%20and%20those%20at%20risk%20of%20late%20relapse&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.05.9584&volume=24&pages=5373-5380&publication_year=2006&author=Bates%2CGJ&author=Fox%2CSB&author=Han%2CC
- How much revenue does https://doi.org/10.1038%2Fmodpathol.2008.160 generate?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18820666?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Immunosuppressive%20regulatory%20T%20cells%20are%20associated%20with%20aggressive%20breast%20cancer%20phenotypes%3A%20a%20potential%20therapeutic%20target&journal=Mod%20Pathol&doi=10.1038%2Fmodpathol.2008.160&volume=21&pages=1527-1532&publication_year=2008&author=Bohling%2CSD&author=Allison%2CKH
- What is the earnings of https://doi.org/10.1158%2F0008-5472.CAN-08-2360?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19244125?
- How much income does http://scholar.google.com/scholar_lookup?&title=Regulatory%20T%20cells%20recruited%20through%20CCL22%2FCCR4%20are%20selectively%20activated%20in%20lymphoid%20infiltrates%20surrounding%20primary%20breast%20tumors%20and%20lead%20to%20an%20adverse%20clinical%20outcome&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-2360&volume=69&pages=2000-2009&publication_year=2009&author=Gobert%2CM&author=Treilleux%2CI&author=Bendriss-Vermare%2CN have?
- https://doi.org/10.1111%2Fj.1365-2559.1991.tb00229.x's total income per month
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1757079's revenue stream
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Pathological%20prognostic%20factors%20in%20breast%20cancer.%20I.%20The%20value%20of%20histological%20grade%20in%20breast%20cancer%3A%20experience%20from%20a%20large%20study%20with%20long-term%20follow-up&journal=Histopathology&doi=10.1111%2Fj.1365-2559.1991.tb00229.x&volume=19&pages=403-410&publication_year=1991&author=Elston%2CCW&author=Ellis%2CIO?
- How much cash flow does https://doi.org/10.1093%2Fjnci%2Fdjp082 have monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19436038 earn?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Ki67%20index%2C%20HER2%20status%2C%20and%20prognosis%20of%20patients%20with%20luminal%20B%20breast%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjp082&volume=101&pages=736-750&publication_year=2009&author=Cheang%2CMC&author=Chia%2CSK&author=Voduc%2CD
- How much does https://doi.org/10.1200%2FJCO.2009.24.9284 generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20194857 generate monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20subtypes%20and%20the%20risk%20of%20local%20and%20regional%20relapse&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.24.9284&volume=28&pages=1684-1691&publication_year=2010&author=Voduc%2CKD&author=Cheang%2CMC&author=Tyldesley%2CS&author=Gelmon%2CK&author=Nielsen%2CTO&author=Kennecke%2CH generate?
- What's the financial gain of https://doi.org/10.1158%2F1078-0432.CCR-05-2434?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16740757's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor-infiltrating%20cytotoxic%20T%20cells%20but%20not%20regulatory%20T%20cells%20predict%20outcome%20in%20anal%20squamous%20cell%20carcinoma&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2434&volume=12&pages=3355-3360&publication_year=2006&author=Grabenbauer%2CGG&author=Lahmer%2CG&author=Distel%2CL&author=Niedobitek%2CG bring in each month?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11431351 produce monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Proliferative%20activity%20of%20intratumoral%20CD8%28%2B%29%20T-lymphocytes%20as%20a%20prognostic%20factor%20in%20human%20renal%20cell%20carcinoma%3A%20clinicopathologic%20demonstration%20of%20antitumor%20immunity&journal=Cancer%20Res&volume=61&pages=5132-5136&publication_year=2001&author=Nakano%2CO&author=Sato%2CM&author=Naito%2CY
- Income figures for https://doi.org/10.1111%2Fj.1365-2559.2007.02919.x
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18184269's financial summary
- How much profit does http://scholar.google.com/scholar_lookup?&title=CD1a%20down-regulation%20in%20primary%20invasive%20ductal%20breast%20carcinoma%20may%20predict%20regional%20lymph%20node%20invasion%20and%20patient%20outcome&journal=Histopathology&doi=10.1111%2Fj.1365-2559.2007.02919.x&volume=52&pages=203-212&publication_year=2008&author=Rocca%2CG&author=Anzalone%2CR&author=Corrao%2CS make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19596912 generate?
- See how much http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20role%20of%20tumor-infiltrating%20CD4%20and%20CD8%20T%20lymphocytes%20in%20breast%20cancer&journal=Anticancer%20Res&volume=29&pages=2445-2451&publication_year=2009&author=Matkowski%2CR&author=Gisterek%2CI&author=Halon%2CA makes per month
- How much does https://citation-needed.springer.com/v2/references/10.1007/s10549-011-1647-3?format=refman&flavour=references bring in each month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Fangfang%20Liu generate?
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Fangfang%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ronggang%20Lang?
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ronggang%20Lang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jing%20Zhao
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jing%20Zhao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xinmin%20Zhang?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xinmin%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gordon%20A.%20Pringle generate?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gordon%20A.%20Pringle%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yu%20Fan
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yu%20Fan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dong%20Yin
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dong%20Yin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Feng%20Gu?
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Feng%20Gu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhi%20Yao make?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhi%20Yao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Li%20Fu bring in?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Li%20Fu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- Learn how profitable https://s100.copyright.com/AppDispatchServlet?title=CD8%2B%20cytotoxic%20T%20cell%20and%20FOXP3%2B%20regulatory%20T%20cell%20infiltration%20in%20relation%20to%20breast%20cancer%20survival%20and%20molecular%20subtypes&author=Fangfang%20Liu%20et%20al&contentID=10.1007%2Fs10549-011-1647-3©right=Springer%20Science%2BBusiness%20Media%2C%20LLC.&publication=0167-6806&publicationDate=2011-06-30&publisherName=SpringerNature&orderBeanReset=true is on a monthly basis
- Earnings of https://citation-needed.springer.com/v2/references/10.1007/s10549-011-1647-3?format=refman&flavour=citation
- How much profit does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral make?
- What's the income generated by https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research each month?
- What is the earnings of https://www.springernature.com/gp/products?
- How much revenue does https://www.springernature.com/gp/librarians generate?
- Check the income stats for https://www.springernature.com/gp/societies
- Get to know https://www.springernature.com/gp/partners's earnings
- How much revenue does https://www.springer.com/ generate?
- How much does https://www.nature.com/ pull in monthly?
- What's the monthly income of https://www.biomedcentral.com/?
- How much profit does https://www.palgrave.com/ generate?
- Explore the financials of https://www.apress.com/
- Get to know what's the income of https://www.springernature.com/gp/legal/ccpa
- What's the financial intake of https://www.springernature.com/gp/info/accessibility?
- What is the earnings of https://support.springernature.com/en/support/home?
- Find out how much https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations earns monthly
- What's the financial outcome of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref